Paradoxically, CD69−/− mice exhibit enhanced tumor immunity and enhanced susceptibility to autoimmune disease raising the possibility that the molecule is a negative regulator of T cell activation [33, 34]. The gene discussed is CD69; the disease is neoplasm.